In a study of anti-PSMA nanobodies in combination with nanobubbles in the diagnostic method of ultrasonography well differentiated prostate cancer cells in comparison with the control group and it was found that this combination is a good method for imaging prostate cancer for diagnostic and therapeutic applications. The gene discussed is FOLH1; the disease is prostate carcinoma.